Melanotan II: what the FDA says

Sellers also write it Melanotan 2 or MT-2.

What the FDA's lists say

The FDA lists Melanotan II among bulk drug substances that were in Category 2, its list of substances that may present significant safety risks, and whose nominations were then withdrawn. Melanotan II is not named on the FDA's 503A category lists.

The FDA's own note on Melanotan II, on that list:

"Compounded drugs containing Melanotan II may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation or peptide-related impurities. Published case reports discuss serious adverse events including melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism."

Source: FDA list of bulk drug substances that may present significant safety risks (current as of April 22, 2026); FDA's 503A category lists (current as of May 14, 2026).

Melanotan II is not on our chart. The cheapest peptide we price:

Cheapest sermorelin on our chart

Tied at $99 a month: CoreAge Rx, Embody, Lttl, Strut Health and Villas Health.

  1. CoreAge Rx logoCoreAge Rxfrom $99 a month, no membership fee. No long-term contractSermorelin injectionChecked November 21, 2026 on CoreAge Rx's own pageCheck price at CoreAge Rx →
  2. Embody logoEmbody$99 a month, after a $49 first monthSermorelin injectionChecked November 21, 2026 on Embody's own pageCheck price at Embody →
  3. Lttl logoLttlfrom $99 a month, visits included. The plan is set at checkoutSermorelin injectionChecked November 21, 2026 on Lttl's own pageCheck price at Lttl →
  4. Strut Health logoStrut Health$99 a month, on auto-refillSermorelin lozengeChecked November 21, 2026 on Strut Health's own pageCheck price at Strut Health →
  5. Villas Health logoVillas Health$99 a month, monthly subscription; $119 as a one-time purchaseSermorelin injectionChecked November 21, 2026 on Villas Health's own pageSee prices

Prices checked by The Pep Chart on , from each program's own page. How we check prices | How we make money

FDA status of every peptide we track